DALLAS, Apr. 2, 2026 / PRZen / Alchemy 43 has appointed Shane Smith as Chief Executive Officer to lead the company’s next phase of growth, with a focus on clinic-level performance, operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results